GENOME THERAPEUTICS CORP
SC 13G/A, EX-1, 2001-01-11
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: GENOME THERAPEUTICS CORP, SC 13G/A, 2001-01-11
Next: TRIMEDYNE INC, S-3, 2001-01-11



<PAGE>

                                                                   EXHIBIT 1

                        AGREEMENT REGARDING JOINT FILING

         The undersigned, Biotechnology Value Fund, L.P., a Delaware limited
partnership, Biotechnology Value Fund II, L.P., a Delaware limited
partnership, BVF Investments L.L.C., a Delaware limited liability company,
BVF Partners L.P., a Delaware limited partnership, and BVF Inc., a Delaware
corporation, hereby agree and acknowledge that the information required by
the Amendment to Schedule 13G, to which this Agreement is attached as an
exhibit, is filed on behalf of each of them. The undersigned further agree
that any further amendments or supplements thereto shall also be filed on
behalf of each of them.

Dated:   January 10, 2001

                  BIOTECHNOLOGY VALUE FUND, L.P.

                  By:      BVF Partners L.P., its general partner

                           By:      BVF Inc., its general partner

                                    By:      /s/  Mark N. Lampert
                                            ------------------------------------
                                            Mark N. Lampert
                                            President

                  BIOTECHNOLOGY VALUE FUND II, L.P.

                  By:      BVF Partners L.P., its general partner

                           By:      BVF Inc., its general partner

                                    By:      /s/  Mark N. Lampert
                                            ------------------------------------
                                            Mark N. Lampert
                                            President

                  BVF INVESTMENTS, L.L.C.

                  By:      BVF Partners L.P., its manager

                           By:      BVF Inc., its general partner

                                    By:      /s/  MARK N. LAMPERT
                                            ------------------------------------
                                            Mark N. Lampert
                                            President

                  BVF PARTNERS L.P.

                  By:      BVF Inc., its general partner

                           By:       /s/  Mark N. Lampert
                                    --------------------------------------------
                                    Mark N. Lampert
                                    President

                  BVF INC.

                  By:       /s/  Mark N. Lampert
                           --------------------------------------------
                           Mark N. Lampert
                           President





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission